LUNG
Pulmonx Corp
NASDAQ: LUNG · HEALTHCARE · MEDICAL DEVICES
$1.28
+6.67% today
Updated 2026-04-30
Market cap
$54.06M
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$1 – $5
Volume
0.6M
Pulmonx Corp (LUNG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-59.70%
Operating margin
-43.80%
ROE
-77.20%
ROA
-23.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $115000.00 | $-1.23M | 100.00% | -819.43% | -1,072.14% |
| 2014 | $332005.00 | $-1.92M | 85.29% | -517.18% | -579.35% |
| 2015 | $19450.00 | $-2.80M | 19.98% | -12,876.06% | -14,398.30% |
| 2016 | $8800.00 | $-2.78M | -15.83% | -28,517.52% | -31,539.27% |
| 2017 | $0.00 | $-5.37M | — | — | — |
| 2018 | $20.00M | $-18.48M | 61.42% | -75.24% | -92.38% |
| 2019 | $32.59M | $-20.70M | 68.77% | -54.73% | -63.52% |
| 2020 | $32.73M | $-32.23M | 64.77% | -98.77% | -98.47% |
| 2021 | $48.42M | $-48.66M | 73.59% | -97.70% | -100.51% |
| 2022 | $53.66M | $-58.92M | 74.29% | -109.27% | -109.80% |
| 2023 | $68.67M | $-60.84M | 73.90% | -90.19% | -88.60% |
| 2024 | $83.79M | $-56.39M | 74.00% | -68.87% | -67.30% |
| 2025 | $90.50M | $-54.00M | 74.19% | -59.30% | -59.67% |